Mark Slaugh
shared:
12/15/2017 7:18:32 PM
Reply"CBD, for now, should not be subject to international drug scheduling, a World Health Organization committee determined..."
— iComply, LLC (@iComplyLLC) December 16, 2017
Our friend CBD is making headway for our favorite plant! Learn more about WHO's conclusion about CBD here-- https://t.co/PAf1QDovXv
